Patent Assignment
Reel/Frame 036807/0234
Change of Name
Recorded: 2015-10-07
Pages: 3
Assignor
APTALIS PHARMATECH, INC.
Executed: 2015-04-29
Assignee
ADARE PHARMACEUTICALS, INC.
100 SOMERSET CORPORATE BLVD., SUITE 2000, BRIDGEWATER, NEW JERSEY, 08807
Covered Properties
(2)
Controlled Release Compositions Comprising Anti-Cholinergic Drugs
Application:
13/202,957 →
Publication:
US 2011/0311626
Controlled Release Compositions Comprising Anti-Cholinergic Drugs
Application:
61/154,504 →
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Corrective Assignment to Correct the Type of Conveyance from Assignment to Name Change, Address, and Submit Translation Previously Recorded on Reel 027136 Frame 0513. Assignor(S) Hereby Confirms the Aptalis Pharma S.R.L. via Martin Luther King, 13 Pessano Con Borgano (Mi) 20060.
Nov 15, 2011
From: EURAND S.P.A.
To: APTALIS PHARMA S.R.L.
Reel/Frame 029762/0390 →
Patent Security Agreement
Oct 31, 2013
From: APTALIS PHARMA CANADA INC.; APTALIS PHARMA US, INC.; APTALIS PHARMATECH, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 031531/0488 →
Termination and Release
Jan 31, 2014
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: APTALIS PHARMA US, INC.; APTALIS PHARMATECH, INC.; APTALIS PHARMA CANADA INC.
Reel/Frame 032149/0111 →
Assignment of Assignor's Interest
Sep 5, 2014
From: GATTI, PAOLO; FABIANI, FLAVIO
To: APTALIS PHARMA S.R.L.
Reel/Frame 033676/0064 →
Assignment of Assignor's Interest
Dec 4, 2014
From: APTALIS PHARMA LTD.
To: APTALIS PHARMA S.R.L.
Reel/Frame 034375/0162 →
Assignment of Assignor's Interest
Sep 25, 2015
From: APTALIS PHARMA S.R.L.
To: ADARE PHARMACEUTICALS S.R.L.
Reel/Frame 036690/0144 →
U.S. Patent Security Agreement
Dec 8, 2015
From: ADARE PHARMACEUTICALS, INC.
To: BANK OF MONTREAL
Reel/Frame 037246/0313 →
Release of Security Interest Recorded at Reel/Frames 037246/0313, 047807/0967, 053474/0276
Sep 22, 2020
From: BANK OF MONTREAL, AS COLLATERAL AGENT
To: ADARE PHARMACEUTICALS, INC.; ADARE DEVELOPMENT I, L.P.; ADARE PHARMACEUTICALS USA, INC.
Reel/Frame 053852/0697 →